| Cynthia Marie Silva, | |
|
230 Old Bartow Eagle Lake Rd, Bartow, FL 33830-3369 | |
| (863) 800-3741 | |
| (862) 800-3741 |
| Full Name | Cynthia Marie Silva |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 230 Old Bartow Eagle Lake Rd, Bartow, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689287831 | NPI | - | NPPES |
| Entity Name | Forefront Telecare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174035612 PECOS PAC ID: 9638319114 Enrollment ID: O20180427000403 |
News Archive
Pevion Biotech AG today announced positive preliminary results from a Phase I study of PEV7, the first vaccine against recurrent vulvovaginal candidiasis (RVVC).
A Phase 2 clinical trial of an investigational universal influenza vaccine intended to protect against multiple strains of the virus has begun in the United States.
A team of scientists from the University of Colorado School of Medicine and the Charles C. Gates Center for Regenerative Medicine at CU Anschutz has reported a more efficient approach to reprogramming a patient's diseased skin cells into stem cells, raising hopes for future clinical trials and potential cures for critical illnesses.
SCOLR Pharma, Inc. today announced it has received a letter from the Food and Drug Administration identifying deficiencies regarding its Abbreviated New Drug Application for extended-release pseudoephedrine.
Three central Texas colleges are applying for a federal grant to train students in the use of electronic medical records, The Texas Tribune reports. "Texas State University in San Marcos and the University of Texas at Austin are partnering with the University of Texas School of Health Information in Houston to apply for a new federal grant in health information that could bring in $6 million across the three campuses.
› Verified 1 days ago
| Entity Name | Silva Family Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124745120 PECOS PAC ID: 5193193217 Enrollment ID: O20221122000559 |
News Archive
Pevion Biotech AG today announced positive preliminary results from a Phase I study of PEV7, the first vaccine against recurrent vulvovaginal candidiasis (RVVC).
A Phase 2 clinical trial of an investigational universal influenza vaccine intended to protect against multiple strains of the virus has begun in the United States.
A team of scientists from the University of Colorado School of Medicine and the Charles C. Gates Center for Regenerative Medicine at CU Anschutz has reported a more efficient approach to reprogramming a patient's diseased skin cells into stem cells, raising hopes for future clinical trials and potential cures for critical illnesses.
SCOLR Pharma, Inc. today announced it has received a letter from the Food and Drug Administration identifying deficiencies regarding its Abbreviated New Drug Application for extended-release pseudoephedrine.
Three central Texas colleges are applying for a federal grant to train students in the use of electronic medical records, The Texas Tribune reports. "Texas State University in San Marcos and the University of Texas at Austin are partnering with the University of Texas School of Health Information in Houston to apply for a new federal grant in health information that could bring in $6 million across the three campuses.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cynthia Marie Silva, 142 Harrington Ct, Davenport, FL 33837-8986 Ph: (773) 962-1089 | Cynthia Marie Silva, 230 Old Bartow Eagle Lake Rd, Bartow, FL 33830-3369 Ph: (863) 800-3741 |
News Archive
Pevion Biotech AG today announced positive preliminary results from a Phase I study of PEV7, the first vaccine against recurrent vulvovaginal candidiasis (RVVC).
A Phase 2 clinical trial of an investigational universal influenza vaccine intended to protect against multiple strains of the virus has begun in the United States.
A team of scientists from the University of Colorado School of Medicine and the Charles C. Gates Center for Regenerative Medicine at CU Anschutz has reported a more efficient approach to reprogramming a patient's diseased skin cells into stem cells, raising hopes for future clinical trials and potential cures for critical illnesses.
SCOLR Pharma, Inc. today announced it has received a letter from the Food and Drug Administration identifying deficiencies regarding its Abbreviated New Drug Application for extended-release pseudoephedrine.
Three central Texas colleges are applying for a federal grant to train students in the use of electronic medical records, The Texas Tribune reports. "Texas State University in San Marcos and the University of Texas at Austin are partnering with the University of Texas School of Health Information in Houston to apply for a new federal grant in health information that could bring in $6 million across the three campuses.
› Verified 1 days ago